Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
350 hedge funds and large institutions have $1.29B invested in Avanos Medical in 2015 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 88 increasing their positions, 123 reducing their positions, and 52 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
27% more capital invested
Capital invested by funds: $1.02B → $1.29B (+$271M)
1% less funds holding
Funds holding: 353 → 350 (-3)
2% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 52
16% less call options, than puts
Call options by funds: $4.83M | Put options by funds: $5.74M
28% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 123
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$39.4M |
| 2 |
CI
Cambiar Investors
Denver,
Colorado
|
+$23.3M |
| 3 |
SCM
Shapiro Capital Management
Atlanta,
Georgia
|
+$17.1M |
| 4 |
LCP
Lombardia Capital Partners
Pasadena,
California
|
+$15.9M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$13.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
RR Partners
New York
|
-$17.9M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$12.4M |
| 3 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
-$9.08M |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$7.94M |
| 5 |
EAM
Edge Asset Management
Seattle,
Washington
|
-$6.5M |
AVNS Hedge Fund Activity: Q4 2015 in Review
350 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2015, worth a combined $1.29B — up 27% from $1.02B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of AVNS and 51 opened new positions — a net loss of 1 holder — while 123 trimmed existing stakes and 88 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $39.4M. The largest seller was RR Partners, exiting entirely with an estimated $17.9M sold.
- 350 institutional investors held Avanos Medical (AVNS) as of Q4 2015, down from 353 in Q3 2015.
- Funds reported $1.29B of Avanos Medical stock for Q4 2015, up 27% quarter-over-quarter.
- 51 funds opened new Avanos Medical positions in Q4 2015 and 52 closed out, a net change of -1 holder.
- The largest Avanos Medical buyer in Q4 2015 was T. Rowe Price Associates, an estimated $39.4M added.
- The largest Avanos Medical seller in Q4 2015 was RR Partners, an estimated $17.9M sold.
Based on aggregated 13F filings for Q4 2015.